GNRH1 and primary ovarian failure: Reviewing of all published studies using GnRH-a or oral contraceptives, data clearly demonstrate that they are too limited to provide conclusive statistical evidence concerning the reduction of premature ovarian failure, even though most studies analyzing the effect of hormonal protection during chemotherapy have shown a reduction of POF in patients receiving GnRH-a or OC during systemic chemotherapy [36].